blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3438668

EP3438668 - DIAGNOSIS AND RISK STRATIFICATION OF FUNGAL INFECTIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.01.2020
Database last updated on 29.10.2024
FormerThe application has been published
Status updated on  04.01.2019
Most recent event   Tooltip10.01.2020Application deemed to be withdrawnpublished on 12.02.2020  [2020/07]
Applicant(s)For all designated states
B.R.A.H.M.S GmbH
Neuendorfstrasse 25
16761 Hennigsdorf / DE
For all designated states
Universität Heidelberg
Grabengasse 1
69117 Heidelberg / DE
[2019/06]
Inventor(s)01 / Brenner, Thorsten
Universität Heidelberg
Friedgasse 33
69509 Mörlenbach / DE
02 / Weigand, Markus Alexander
Universität Heidelberg
Am Weidacker 30
35435 Wettenberg / DE
03 / Uhle, Florian
Universität Heidelberg
Am Dorf 36
69124 Heidelberg / DE
04 / Wilson, Darius Cameron
BRAHMS GmbH
Simon-Dach-Strasse 37
10245 Berlin / DE
 [2019/06]
Representative(s)Simandi, Claus
Simandi Patentanwälte Kurfürstendamm 45
10719 Berlin / DE
[N/P]
Former [2019/06]Simandi, Claus
Badehausallee 55
27476 Cuxhaven / DE
Application number, filing date17185036.504.08.2017
[2019/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3438668
Date:06.02.2019
Language:EN
[2019/06]
Search report(s)(Supplementary) European search report - dispatched on:EP03.11.2017
ClassificationIPC:G01N33/68, G01N33/74
[2019/06]
CPC:
G01N33/68 (EP); G01N33/6893 (US); G01N33/74 (EP);
G01N2333/525 (US); G01N2333/5412 (US); G01N2333/5428 (US);
G01N2333/57 (US); G01N2800/26 (EP,US); G01N2800/50 (US);
G01N2800/52 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/06]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:DIAGNOSE UND RISIKOSTRATIFIZIERUNG VON PILZINFEKTIONEN[2019/06]
English:DIAGNOSIS AND RISK STRATIFICATION OF FUNGAL INFECTIONS[2019/06]
French:DIAGNOSTIC ET STRATIFICATION DES RISQUES D'INFECTIONS FONGIQUES[2019/06]
Examination procedure07.08.2019Application deemed to be withdrawn, date of legal effect  [2020/07]
19.09.2019Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2020/07]
Fees paidPenalty fee
Additional fee for renewal fee
31.08.201903   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO9707214  (US GOV HEALTH & HUMAN SERV [US], et al) [X] 1,3,4,7,14 * pg 13, l 18-pg 14, l 11; pg 32, l 17-l 30; cl 1-2. * [Y] 2-12;
 [X]US2015011017  (BERGMANN ANDREAS [DE], et al) [X] 1,3,5-7,10-12,14 * par 0006, 0010, 0021, 0023, 0029-0031; cl 2, 7, 9, 19; fig 3. *;
 [XI]  - David Andaluz-ojeda ET AL, "Superior accuracy ofmid-regional proadrenomedullin formortality prediction insepsis withvarying levels ofillness severity", Intensive Care, doi:10.1186/s13613-017-0238-9, (20170101), page 15, URL: https://annalsofintensivecare.springeropen.com/track/pdf/10.1186/s13613-017-0238-9?site=annalsofintensivecare.springeropen.com, XP055418338 [X] 1-3,5-13 * abstract, pg 1-6, pg 7, left col. * [I] 4

DOI:   http://dx.doi.org/10.1186/s13613‑017‑0238‑9
 [Y]  - CHRIST-CRAIN MIRJAM ET AL, "Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study", CRITICAL CARE, BIOMED CENTRAL LTD., LONDON, GB, (20051115), vol. 9, no. 6, doi:10.1186/CC3885, ISSN 1364-8535, pages R816 - R824, XP021012417 [Y] 2-12 * abstract, pg 817-822, fig 1,2. *

DOI:   http://dx.doi.org/10.1186/cc3885
 [Y]  - DE LA TORRE-PRADOS MARIA V ET AL, "Mid-regional pro-adrenomedullin as prognostic biomarker in septic shock", MINERVA ANESTESIOLOGICA : GIORNALE ITALIANO DI ANESTESIA E DI ANALG, SOCIETÀ ITALIANA DI ANESTESIOLOGIA, IT, (20160701), vol. 82, no. 7, ISSN 1827-1596, pages 760 - 766, XP009192235 [Y] 2-12 * abstract, pg 760-764. *
 [T]  - SEBASTIAN DECKER ET AL, "Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock-Results of a Combined Clinical and Experimental Investigation", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, (20170818), vol. 18, no. 8, doi:10.3390/ijms18081796, page 1796, XP055417185 [T] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.3390/ijms18081796
by applicantEP0622458
 EP1488209
 EP1121600
 EP2111552
    - KITAMURA K; SAKATA J; KANGAWA K; KOJIMA M; MATSUO H; ETO T., "Cloning and characterization of cDNA encoding a precursor for human adrenomedullin", Biochem Biophys Res Commun, (19930000), vol. 194, doi:doi:10.1006/bbrc.1993.1881, pages 720 - 725, XP024767316

DOI:   http://dx.doi.org/10.1006/bbrc.1993.1881
    - Clin Chem., (19980000), vol. 44, pages 571 - 7
    - Clin Chem, (19980000), vol. 44, pages 571 - 7
    - UEDA S; NISHIO K; MINAMINO N; KUBO A; AKAI Y; KANGAWA K et al., "Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome", Am J Respir Crit Care Med, (19990000), vol. 160, doi:doi:10.1164/ajrccm.160.1.9810006, pages 132 - 6, XP055052609

DOI:   http://dx.doi.org/10.1164/ajrccm.160.1.9810006
    - KOBAYASHI K; KITAMURA K; ETOH T; NAGATOMO Y; TAKENAGA M; ISHIKAWA T et al., "Increased plasma adrenomedullin levels in chronic congestive heart failure", Am Heart J, (19960000), vol. 131, doi:doi:10.1016/S0002-8703(96)90185-4, pages 994 - 8, XP004530584

DOI:   http://dx.doi.org/10.1016/S0002-8703(96)90185-4
    - KOBAYASHI K; KITAMURA K; HIRAYAMA N; DATE H; KASHIWAGI T; IKUSHIMA I et al., "Increased plasma adrenomedullin in acute myocardial infarction", Am Heart J, (19960000), vol. 131, doi:doi:10.1016/S0002-8703(96)90270-7, pages 676 - 80, XP004537851

DOI:   http://dx.doi.org/10.1016/S0002-8703(96)90270-7
    - STRUCK J; TAO C; MORGENTHALER NG; BERGMANN A, "Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients", Peptides, (20040000), vol. 25, doi:doi:10.1016/j.peptides.2004.06.019, pages 1369 - 72, XP004551479

DOI:   http://dx.doi.org/10.1016/j.peptides.2004.06.019
    - MORGENTHALER NG; STRUCK J; ALONSO C; BERGMANN A., "Measurement of mid-regional pro-adrenomedullin in plasma with an immunoluminometric assay", Clin Chem, (20050000), vol. 51, pages 1823 - 9
    - CHRIST-CRAIN M; MORGENTHALER NG; STRUCK J; HARBARTH S; BERGMANN A; MULLER B., "Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study", Crit Care, (20050000), vol. 9, doi:doi:10.1186/cc3885, pages R816 - 24, XP021012417

DOI:   http://dx.doi.org/10.1186/cc3885
    - HASHIDA S; KITAMURA K; NAGATOMO Y; SHIBATA Y; IMAMURA T; YAMADA K et al., "Development of an ultra-sensitive enzyme immunoassay for human pro-adrenomedullin N-terminal peptide and direct measurement of two molecular forms of PAMP in plasma from healthy subjects and patients with cardiovascular disease", Clin Biochem, (20040000), vol. 37, pages 14 - 21
    - Mycoses, vol. 58, pages 399 - 407
    - Crit Care Med, vol. 37, pages 2519 - 2526
    - BEISHUIZEN A; DEBETS-OSSENKOPP YJ et al., "Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients", Intensive Care Med, (20070000), vol. 33, doi:doi:10.1007/s00134-007-0791-z, pages 1694 - 1703, XP019536406

DOI:   http://dx.doi.org/10.1007/s00134-007-0791-z
    - SINGER M; DEUTSCHMAN CS; SEYMOUR CW et al., "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3", Jama, (20160000), vol. 315, pages 801 - 81
    - EGGIMANN P; GARBINO J, "Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosuppressed patients", Lancet Infect Dis, vol. 3, doi:doi:10.1016/S1473-3099(03)00801-6, pages 685 - 702, XP004809957

DOI:   http://dx.doi.org/10.1016/S1473-3099(03)00801-6
    - COMBES A; MOKHTARI M; COUVELARD A et al., "Clinical and autopsy diagnoses in the intensive care unit: a prospective study", Arch Intern Med, (20040000), vol. 164, pages 389 - 392
    - ABE M; KIMURA M; ARAOKA H et al., "Is initial serum (1,3)-beta-d-glucan truly associated with mortality in patients with candidaemia?", Clin Microbiol Infect, (20160000), vol. 22, page 576
    - LEVY MM et al., "2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference", Crit Care Med., (20030400), vol. 31, no. 4, pages 1250 - 6
    - BONE et al., CHEST, (19920000), vol. 101, no. 6, pages 1644 - 55
    - ASCIOGLU S; REX JH; DE PAUW B; BENNETT JE; BILLE J; CROKAERT F; DENNING DW; DONNELLY JP; EDWARDS JE; ERJAVEC Z, "Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer", Mycoses Study Group of the National Institute of Allergy and Infectious Diseases; .Clin Infect Dis., (20020101), vol. 34, no. 1, pages 7 - 14
    - DE PAUW B; WALSH TJ; DONNELLY JP; STEVENS DA; EDWARDS JE; CALANDRA T; PAPPAS PG; MAERTENS J; LORTHOLARY O; KAUFFMAN CA, "European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group", National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.Clin Infect Dis., (20080615), vol. 46, no. 12, pages 1813 - 21
    - HULTSCHIG C et al., Curr Opin Chem Biol., (20060200), vol. 10, no. 1, pages 4 - 10
    - Encyclopedia of chemical technology, John Wiley & Sons, (19930000), vol. 15, pages 518 - 562
    - GUMBINGER C; HUG A; MURLE B et al., "Early blood-based microbiological testing is ineffective in severe stroke patients", J Neurol Sci, (20130000), vol. 325, pages 46 - 50
    - MISCHNIK A; MIETH M; BUSCH CJ et al., "First evaluation of automated specimen inoculation for wound swab samples by use of the Previ Isola system compared to manual inoculation in a routine laboratory: finding a cost-effective and accurate approach", J Clin Microbiol, (20120000), vol. 50, pages 2732 - 2736
    - ZOU M; TANG L; ZHAO S et al., "Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis", PLoS One, (20120000), vol. 7, page e43347
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.